Analysis of Muscular Properties in Patients With MFS and EDS
NCT ID: NCT05720923
Last Updated: 2025-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
65 participants
OBSERVATIONAL
2023-02-15
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To assess the ability to develop muscle strength;
* Muscle and tendon morphology involved in muscle contractions/relaxation;
* Neuromuscular functionality.
Participants will be take part in the study by performing a test for the assessment of the neuromuscular activity (voluntary muscle contractions) and undergoing a muscle ultrasound for the study of muscles and tendons.
Researchers will compare the two groups with a control group to see potential differences in the morphological and neuromuscular structures of syndromic patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Marfan Syndrome (MFS) and Facial Dysmorphism: Non-invasive 3D Assessment
NCT05702476
Functional and Morphological Characterization of Multiple Osteochondromas Disorder
NCT06703736
Single-Session "Empowered Relief" Class for Marfan Syndrome and Related Conditions
NCT05980104
Effect on the Quality of Life of a Therapeutic Education Program in Patients With Marfan Syndrome
NCT04731493
Limited-efficacy Testing of SDS and NEMOST for Early Onset Neuromuscular Scoliosis
NCT04021784
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Like MFS, Ehlers-Danlos Syndrome (EDS) is a rare autosomal dominantly inherited connective tissue disorder. EDS is caused by mutations that cause impaired collagen production, therefore of pathological phenotypes affecting connective tissues such as the integumentary system, the system skeletal system, the cardiovascular system and other organs and tissues. Joint dislocations, musculoskeletal pain, atrophic scarring, and severe scoliosis may occur in patients with EDS.
To date, there are no studies in literature assessing neuromuscular properties in patients with MFS and EDS.
However, the analysis of the musculo-tendon morphological and mechanical properties makes it possible to evaluate the muscle capacity especially in pathological conditions, where the morphology and tendon mechanics are altered, thus providing pivotal information on changes in the contractile capacity of the muscle.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MFS_f
Patients with Marfan syndrome with fatigue
Analysis with Ergometer
The analysis with the ergometer aims at assessing neuromuscular function
MFS_nf
Patients with Marfan syndrome without fatigue
Analysis with Ergometer
The analysis with the ergometer aims at assessing neuromuscular function
EDS_f
Patients with Ehlers Danlos syndrome with fatigue
Analysis with Ergometer
The analysis with the ergometer aims at assessing neuromuscular function
EDS_nf
Patients with Ehlers Danlos syndrome without fatigue
Analysis with Ergometer
The analysis with the ergometer aims at assessing neuromuscular function
Volunteers
Healthy adult volunteers without fatigue
Analysis with Ergometer
The analysis with the ergometer aims at assessing neuromuscular function
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Analysis with Ergometer
The analysis with the ergometer aims at assessing neuromuscular function
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed informed consent;
Exclusion Criteria
* Presence of cardiac pacemaker;
* Epilepsia;
* Presence neurological disorders or circulatory diseases in the lower limbs;
* Pregnancy.
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Milan
OTHER
IRCCS Policlinico S. Donato
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alessandro Pini
Unit Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giuliana Trifirò, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Policlinico S. Donato
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Policlinico San Donato
San Donato Milanese, Lombardy, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MUSCLE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.